Immunic Appoints Jaa Roberson as Chief People Officer

Article summary

– Appointment Supports Immunic's Strategy to Build a Leading Multiple Sclerosis Organization Ahead of Potential Transition to Fully Integrated Commercial Company – NEW YORK, Oct. 19, 2026 — Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the...